|
Alzheimer's Disease:
Toward Prevention
| Course Number |
LWH710
|
| Objectives |
At the end of this course, you will 11)
describe the physiological changes resulting in plaque formation, 2)
describe the symptoms of the disease, and 3) analyze interventions that
may slow or prevent the disease.
|
| Credit Hours and Fee |
3.0 CE Credit Hours with a fee of $24.00 |
| Instructor |
Rudolf Klimes, PhD (Indiana University), MPH
(Johns Hopkins University);
Adjunct Professor at Folsom Lake
College, Folsom CA. |
Welcome
to this
3-contact-hour Continuing Education course
((RN-CEP 11430, MFT- PCE
39) with instant online processing
and certification 24/7. Study the course below, take the 12-question
multiple-choice
TEST, register and pay online. If
you score 75% or above, you may print your CE certificate on your printer as
soon as you finish.
If you have difficulty printing your certificate,
click here.
You may retake the test once.
TEST,
Disclaimer: This course is for general background information
for nurses and other health professionals. It was compiled mainly from existing
research and university documents. It is a continuing education course and should not
be used as an authorative document for prevention. Readers are invited to email
updates and possible content additions to
edu@learnwell.org.
Questions
for Self-study
Do the following for self-study. Do not submit the answers.
AD stands for Alzheimer's Disease.
AD is the most common form of dementia in old people.
AD was discovered by a doctor who examined brain tissues.
AD affects only old people.
AD can be now be fully prevented.
Introduction
Dementia is a brain disorder that seriously affects a person’s ability to
carry out daily activities. Alzheimer’s disease (AD) is the most common form of
dementia among older people. It involves the parts of the brain that control
thought, memory, and language. Every day scientists learn more, but right now
the causes of AD are still unknown, and there is no cure.
Scientists think that up to 4 million Americans suffer from AD. The
disease usually begins after age 60, and risk goes up with age. While younger
people also may get AD, it is much less common. About 3 percent of men and women
ages 65 to 74 have AD, and nearly half of those age 85 and older may have the
disease. It is important to note, however, that AD is not a normal part of
aging.
AD is named after Dr. Alois Alzheimer, a German doctor. In 1906, Dr.
Alzheimer noticed changes in the brain tissue of a woman who had died of an
unusual mental illness. Source:
http://www.alzheimers.org/pubs/adfact.html
AD begins slowly. At first, the only symptom may be mild forgetfulness.
People with AD may have trouble remembering recent events, activities, or the
names of familiar people or things. Simple math problems may become hard to
solve. Such difficulties may be a bother, but usually they are not serious
enough to cause alarm.
However, as the disease goes on, symptoms are more easily noticed and
become serious enough to cause people with AD or their family members to seek
medical help. For example, people in the later stages of AD may forget how to do
simple tasks, like brushing their teeth or combing their hair. They can no
longer think clearly. They begin to have problems speaking, understanding,
reading, or writing. Later on, people with AD may become anxious or aggressive,
or wander away from home. Eventually, patients need total care. Source:
http://www.alzheimers.org/pubs/adfact.html#symptoms
Read about Alzheimer's symptoms, diagnosis and treatment:
http://www.alz.org/hc/overview/symptoms.htm and Basic Facts:
http://www.alzheimers-research.co.uk/ and AD overview:
http://www.lef.org/protocols/prtcl-006.shtml
Active Lifestyle and AD Prevention:
http://www.alzheimersupport.com/library/showarticle.cfm?ID=1425
AD Deaths Annually: 44,536 (1999)
Age-Adjusted Death Rate: 16.5 deaths per 100,000 population
(1999)
Cause of Death Rank Among Americans: 8th (1999)
Source:
National Vital Statistics Reports, Vol. 49, No. 8

1.
A-BETA (Amyloid beta) Formation
One of the proteins found in the out layer of brain
cells is APP. The ends of these proteins are sometimes cut off by enzymes,
namely the beta and gamma secretase, and the resulting fragment is the A-beta.
That A-beta can accumulate to form into clusters or plaque and cause problems.
The A-beta needs to be cleaned out of the brain before it forms cluster.
Or some way needs to be found to inhibit the secretase. Anything that will do
that will contribute to the prevention of Alzheimer's. A life of regular
exercise may, in part, contribute to that.
The 42-43 amino acid amyloid beta (A-beta, A4) protein described by
Glenner and Wong is now known to be a major component of both diffuse and
neuritic senile plaques (SP). These extracellular structures may be found in the
brains of nondemented persons with or without a history of head injury
(including boxers), and in individuals afflicted with a variety of
neurodegenerative disorders: Alzheimer's disease (AD), Down's syndrome (trisomy
21), Creutzfeldt-Jakob disease (CJD) and others. Source:
http://www.adrc.wustl.edu/adrc/abeta_SP.html
Research articles on A-Beta:
http://www.math.ubc.ca/~ais/website/refs/amyloidrefs.html

2. FIBRIL Formation
As we saw above, the left-over protein parts called
A-betas are the problem. When healthy, they are helical like coiled springs.
When cut off, they sometimes loose their coil, flatten out, and then cluster
together to form beta-sheet structures and these, when stuck together, are
fibrils. Two drugs that may block the A-beta sheets from forming are under
development. If that happens, Alzheimer's would be prevented.
In healthy neurons, microtubules form structures like train tracks, which
guide nutrients and molecules from the bodies of the cells down to the ends of
the axon. Tau normally holds together the “railroad ties” or connector pieces of
the microtubule tracks. However, in AD tau is changed chemically, and this
altered tau twists into paired helical filaments – two threads of tau wound
around each other. These filaments aggregate to form neurofibrillary tangles.
When this happens, the tau no longer holds the railroad tracks together and the
microtubules fall apart. This collapse of the transport system first may result
in malfunctions in communication between nerve cells and later may lead to
neuronal death that contributes to the development of dementia Source:
http://www.alzheimers.org/pubs/prog00.htm#Amyloid%20Plaques
Tau
normally undergoes a process called phosphorylation in which molecules called
phosphates are added to the protein. Scientists have found that tau in
the tangles that characterize AD and other neurodegenerative diseases is
composed of overly and abnormally phosphorylated tau. They speculate that
this process causes the tau to aggregate into tangled filaments instead
of attaching itself to the microtubules, thereby destabilizing the microtubules.
Source:
http://www.alzheimers.org/pubs/conv09n4.html

3.PLAQUE Formation and Buildup
The above mentions A-beta fibrils connect with SAP proteins and with
each other to form an insoluble plaque that is hard for the body to clean out.
With time, this plague replaces many brain cells. Then the brain cannot produce
enough of the neuron transmitter acetylcholine, and there is a loss of memory
and cognition. Some drugs that will bind with SAP before it can bind with A-beta
fibrils are under development. This too will contribute to the prevention of
Alzheimer's.
In AD, plaques develop first in areas of the brain used for memory and
other cognitive functions. They consist of largely insoluble (cannot be
dissolved) deposits of beta-amyloid – a protein fragment snipped from a larger
protein called amyloid precursor protein (APP) – intermingled with portions of
neurons and with non-nerve cells such as microglia (cells that surround and
digest damaged cells or foreign substances that cause inflammation) and
astrocytes (glial cells that serve to support and nourish neurons). Plaques are
found in the spaces between the brain’s nerve cells. Source:
http://www.alzheimers.org/pubs/prog00.htm#Amyloid%20Plaques

4. NEURON Death
At this stage, Alzheimer's
patients have very high levels of the brain chemical glutamate, making brain
cells insensitive to glutamate bursts that help in new memory development. Thus
the patient cannot remember. One drug that regulates glutamate has been approved
in Europe.
5.
Moving toward Prevention
Currently there is no proven way
to prevent AD. A vaccine is being developed and early testing is under way.
Various studies are under way to clarify the role of some common medications in
the prevention of AD. Among these are non-steroidal anti-inflammatory drugs (NSAIDs),
antioxidants such as vitamin E, estrogen replacement therapy, and gingko biloba.
None of these are currently recommended, all of these have side effects, and all
can interact with other medications. Consult a healthcare provider before
considering or taking them. Source:
http://www.nlm.nih.gov/medlineplus/ency/article/000760.htm#prevention
AD is a disease that turns parts of the brain into a
sticky mess and thus inhibits its functions. Thus the onset of the disease has
to be prevented or stopped early. Once the brain tissue is destroyed, it
cannot be restored. The prevention of DA can take a number of approaches:
1.Prevent particles that may form plaque from forming. 2. Prevent these
particles from forming plaque. 3 Flush out of the brain particles that can
accumulate and cause plaque. 4. Destroy the particles that may form plaque. 5.
Destroy the plaque.
At present, some clinical trials are under way for
medications that may do one or more of these things. Lifestyle and other
remedies may contribute to the prevention of AD as outlined above.
At this time, there is not enough research that
indicates that AD can be prevented or delayed. But there are partial prevention
strategies that may slow the progression of the disease or may have
elements of prevention. In England, three drugs have been developed that have
been approved there and that deal with some aspects of AD. Some studies have
suggested populations that have less AD and thus may practice prevention
strategies without knowing it. And some populations have more AD. There are some
clinical trials under way, and these may discover areas that may in time uncover
prevention strategies and preventive or healing drugs. Here are presented two
things individuals may do.
First of all, the practicing of a Daily Health at
http://www.klimes.org/dailyhealth.htm and a healthy lifestyle may be, to
some extend and to some people, preventive of many diseases, including
Alzheimer's.
Daily Health
|
|
Exercise
vigorously for 30 minutes |
|
Eat
5 servings of fruit and vegetables |
|
Enjoy
TobaccoFree & DrugFree living |
|
Embrace
faith, hope and love. |
Secondly, the following practices are not harmful
and may with time prove preventive of AD for some individuals:
* Drink 8 glasses of water a day. The body needs to
replace the water lost in perspiration and excretion to flush out selected
particles.
* Maintain your immune system through, among others, adequate sleep and rest
time, in order to give it strength to fight.
* Use Gingko Biloba Herbal Tea as a supplementary hot drink. There is some
indication that it may improve memory functions. (Do not use it if
you are using blood-thinning medications.)
* Reduce your stress and tension through meditation and relaxation exercises.
Stress hinders the functions of the immune system.
* Keep mentally active by reading, studying, and mental games. An active brain
may be less vulnerable to attack.

6.
Alzheimers Library
Speak to an Information Specialist at 800-438-4380.
Progress Report:
http://www.alzheimers.org/pubs/prog00.htm
enter Watch of Clinical Trials:
http://www.centerwatch.com/patient/studies/CAT11.html
TEST
Study
this web-site for 3 hours for an approved (RN-CEP 11430, MFT- PCE 39) 3-hours
Continuing Education Certificate (0.3 CEUs).
Click
here for the self-correcting test & online payment, and 2) receive your
certificate immediately online. All is online, nothing by post-mail.
|